✦ LIBER ✦

Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial

✍ Scribed by Matthew R Weir; Michael A Weber; Joel M Neutel; Jennifer Vendetti; Eric L Michelson; Rebecca Y Wang

Book ID: 117599754
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 155 KB
Volume: 14
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(00)01304-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of candesartan cilexetil as add-

Effects of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial

✍ M.R. Weir; M.A. Weber; J.M. Neutel; J. Vendetti; S. Harris; E.L. Michelson; R. W 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

Clinical Efficacy of Topiramate as Add-O

Clinical Efficacy of Topiramate as Add-On Therapy in Refractory Partial Epilepsy: The European Experience

✍ Elinor Ben-Menachem 📂 Article 📅 1997 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 234 KB

Clinical efficacy and tolerability of al

Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism

✍ A.C. Pessina; L. Ciccariello; F. Perrone; V. Stoico; G. Gussoni; A. Scotti; M. M 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of D-α-Tocopherol (Vitamin E) as Add-on Therapy in Uncontrolled Epilepsy

✍ G. B. Raju; M. Behari; K. Prasad; G. K. Ahuja 📂 Article 📅 1994 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 548 KB

C33 - Efficacy of moexipril as add-on th

C33 - Efficacy of moexipril as add-on therapy to hydrochlorothiazide in patients with moderate to severe hypertension

✍ K Dickstein; M Stimpel 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 218 KB

A double-blind, placebo-controlled evalu

A double-blind, placebo-controlled evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures

✍ T Rentmeester; A Janssen; J Hulsman; F Scholtes; B van der Kleij; J Overweg; J M 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Sixty-two patients with uncontrolled partial seizures participated in a 12-week, double-blind, placebo-controlled add-on-trial. Thirty-two patients received loreclezole and 30 a placebo as add-on therapy. Loreclezole was targeted at a plasma level of 1-2 mg/l. In spite of an antiepileptic therapy, u